We are live on ! Find out more
ITDA

iShares LifePath Target Date 2025 ETF

Delisted

ITDA was delisted on the 15th of November, 2024.

0 hedge funds and large institutions have $0 invested in iShares LifePath Target Date 2025 ETF in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 10 (-1)

100% less capital invested

Capital invested by funds: $13K → $0 (-$13K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
Holders Change
-1
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SS
Sunbelt Securities
Texas
-$13K
Name Holding Trade Value Shares
Change
Change in
Stake
SS
1
Sunbelt Securities
Texas
-$13K -434 Closed

ITDA Hedge Fund Activity: Q4 2024 in Review

0 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in iShares LifePath Target Date 2025 ETF (ITDA) for Q4 2024, worth a combined $0 — down 100% from $13K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ITDA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Sunbelt Securities, exiting entirely with an estimated $13K sold.

  • 0 institutional investors held iShares LifePath Target Date 2025 ETF (ITDA) as of Q4 2024, down from 1 in Q3 2024.
  • Funds reported $0 of iShares LifePath Target Date 2025 ETF stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new iShares LifePath Target Date 2025 ETF positions in Q4 2024 and 1 closed out, a net change of -1 holder.
  • The largest iShares LifePath Target Date 2025 ETF seller in Q4 2024 was Sunbelt Securities, an estimated $13K sold.

Based on aggregated 13F filings for Q4 2024.